| Accession Number | 0000937556-26-000008 |
|---|---|
| Form Type | 4 |
| Filing Date | Jan 31, 2026 |
| Document Date | Jan 28, 2026 |
| Document | View SEC Filing |
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
EVP, Ops & Clinical Research | Common Stock | โ | Jan 28, 2026 | Exercise/Conversion | 30,000 | $37.84 | $1,135,200.00 | 59,589 | Direct | โ | View Details | |
EVP, Ops & Clinical Research | Common Stock | โ | Jan 28, 2026 | Sale | 11,924 | $136.56 | $1,628,341.44 | 47,665 | Direct | โ | View Details | |
EVP, Ops & Clinical Research | Common Stock | โ | Jan 28, 2026 | Sale | 6,560 | $137.22 | $900,163.20 | 41,105 | Direct | โ | View Details | |
EVP, Ops & Clinical Research | Common Stock | โ | Jan 28, 2026 | Sale | 196 | $138.09 | $27,065.64 | 40,909 | Direct | โ | View Details | |
EVP, Ops & Clinical Research | Non-Qualified Stock Option (Right to Buy) | Derivative | Jan 28, 2026 | Exercise/Conversion | 30,000 | $0.00 | $0.00 | 0 | Direct | โ | View Details |